Which companies overlap with CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.'s portfolio?

Top competitors by shared drug class: Bayer, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Pfizer, Beijing Tiantan Hospital, Asan Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. pipeline: 1 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 4 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Cleviprex®	Cleviprex®	marketed	Dihydropyridine calcium channel blocker	L-type calcium channel	Cardiovascular
Liposomal cytarabine-daunorubicin for injection	Liposomal cytarabine-daunorubicin for injection	phase 3	Liposomal chemotherapy combination	DNA polymerase (cytarabine); Topoisomerase II (daunorubicin)	Oncology
SYH2053injection	SYH2053injection	phase 3	PD-1 inhibitor	PD-1	Oncology
SYH2053/placebo injection	SYH2053/placebo injection	phase 3	PCSK9 inhibitor	PCSK9	Cardiovascular
SYH2053	SYH2053	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Cardiovascular · 2
Oncology · 2
Diabetes · 1
Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 3 shared drug classes
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 3 shared drug classes
Pfizer · 3 shared drug classes
Beijing Tiantan Hospital · 2 shared drug classes
Asan Medical Center · 2 shared drug classes
Allergan · 2 shared drug classes
Addpharma Inc. · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.:

Cite this brief

Drug Landscape (2026). CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd. Accessed 2026-05-17.